ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Synergistic Effects of Cucumis Sativus and Glimepiride on Blood Glucose Reduction: Implications for Diabetes Management

Ikechukwu Sonne Mbagwu,Daniel Lotanna Ajaghaku,Paul Chinwuba,King-david Ikenna Ahuchaogu,Uchechukwu Harrison Orji,Amara Anwuchaepe Ajaghaku.



Abstract
Download PDF Cited by 0 ArticlesPost

Background: This study investigated the interactive effects of Cucumis sativus (cucumber) extract and glimepiride on blood glucose reduction in an alloxan-induced diabetic mouse model.
Method: Qualitative and quantitative phytochemical analyses of the Cucumis sativus extract were performed. Acute toxicity studies were conducted using the Lorke's method. The antidiabetic median effective doses (ED50) of Cucumis sativus extract and glimepiride were determined. Various combinations of the extract and glimepiride were evaluated for their effects on blood glucose levels.
Results: The Cucumis sativus extract yielded 9.2% yield and contained flavonoids, tannins, cardiac glycosides, steroids, and terpenoids, with terpenoids being the most abundant (26.27 mg/g). Both Cucumis sativus extract and glimepiride exhibited dose-dependent reductions in blood glucose levels, with ED50 values of 518 mg/kg and 0.20 mg/kg, respectively. The combination of glimepiride and Cucumis sativus extract at half their ED50 doses (0.10:259 mg/kg) resulted in an additive effect (CI=1), whereas the combination at doses of 0.05:388.5 mg/kg showed synergism (CI

Key words: Drug-food interaction, Diabetes, Cucumis sativus, Glimepiride, Antidiabetic efficacy, Blood glucose reduction, Combination therapy







Bibliomed Article Statistics

115
26
20
26
24
18
R
E
A
D
S

24

25

21

16

15

9
D
O
W
N
L
O
A
D
S
080910111201
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.